Clinical Trials Directory

Trials / Unknown

UnknownNCT03255408

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

Role of Cerebral Blood Flow on Ventilatory Stability During Sleep in Normoxia and Intermittent Hypoxia

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

A prospective double blind, placebo-controlled, randomized cross-over trial to evaluate the effect of lowering cerebral blood flow on the ventilatory chemoreflexes (acute hypoxic and hypercapnic ventilatory responses).

Detailed description

The investigators will explore the relationship between changes in Cerebral Blood Flow (CBF) and ventilatory chemoreflexes i.e. Acute Ventilatory Response to Hypoxia (AHVR) and Acute Hypercapnic Ventilatory Response (HCVR) before, during and after sleep under normoxic conditions and sleep accompanied by isocapnic Intermittent Hypoxia (IH) among healthy human study participants. A pharmacological intervention will be utilized to manipulate the CBF in a randomized order. The study participants will also be randomly assigned the order to sleep either under normoxia or IH exposure. The experiments will be separated from one another with an interval of sufficient drug and IH exposure washout period. The venous blood samples and urinary samples will be collected for the vascular biomarkers.

Conditions

Interventions

TypeNameDescription
DRUGDrug Lowering Cerebral Blood Flow (CBF) and Normoxia SleepThe study participants will take Cerebral Blood Flow (CBF) lowering drug and sleep under Normoxia Exposure
DRUGDrug Lowering CBF and Intermittent Hypoxia SleepThe study participants will take Cerebral Blood Flow (CBF) lowering drug and sleep under Intermittent Hypoxia (IH) Exposure
DRUGPlacebo and Normoxia SleepThe study participants will take Placebo and sleep under Normoxia Exposure
DRUGPlacebo and Intermittent Hypoxia SleepThe study participants will take Placebo and sleep under Intermittent Hypoxia (IH) Exposure

Timeline

Start date
2023-01-01
Primary completion
2024-12-30
Completion
2024-12-30
First posted
2017-08-21
Last updated
2022-11-04

Source: ClinicalTrials.gov record NCT03255408. Inclusion in this directory is not an endorsement.